Leading the Way in Life Science Technologies

GEN Exclusives

More »

Sounds of Science Podcasts

More »
March 09, 2017

Cancer Immunotherapy: CAR T as 'Car Race'

Sounds of Science Podcast

Cancer Immunotherapy: CAR T as 'Car Race'

Source: NIH


    Brad Loncar, CEO of Loncar Investments, weighs in on recent developments in the scramble to develop CAR T cancer immunotherapies. How significant a setback is Juno Therapeutics’ halting development of JCAR015? How could some second-tier companies yet come out on top in the “car race”?

Related content

  • You’re all set! Thank you for subscribing to GEN Highlights.